<DOC>
	<DOCNO>NCT02697006</DOCNO>
	<brief_summary>The purpose study collect prospective safety performance information i-COR® device use synchronized cardiac assist set combine heart-lung failure high risk percutaneous intervention procedure catheterization lab .</brief_summary>
	<brief_title>Synchronized Cardiac Assist Cardiogenic Shock</brief_title>
	<detailed_description />
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Cardiogenic</mesh_term>
	<criteria>Patients cardiogenic shock set acute myocardial infarction Patients undergoing high risk coronary revascularization procedure ( e.g. , multivessel disease , leave main , last patent conduit intervention ) catheterization lab . Cardiogenic shock define Systolic blood pressure &lt; 90 mmHg least 30 min Inotropes need maintain blood pressure &gt; 90 mmHg Clinical sign heart insufficiency pulmonary congestion Signs end organ hypoperfusion least one follow criterion : Altered mental status cold , damp skin extremity oliguria ( ≤ 30 mL/h ) serum lactate &gt; 2.0 mmol/L Written consent patient legal caregiver Age &gt; 85 year Cardiac arrest hospital return spontaneous circulation ( ROSC ) &gt; 10 min Coma fix pupil induced drug ; Mechanical cause cardiogenic shock ( ventricular septal defect papillary muscle rupture ) Noncardiogenic cause shock ( bradycardia , sepsis , hypovolemia , etc . ) Fever ( Body temperature &gt; 38.0 °C ) evidence sepsis Onset cardiogenic shock &gt; 6 h enrollment ; Lactate &gt; 22 mmol/L ; Massive pulmonary embolism ; Severe peripheral arterial occlusive disease preclude insertion femoral arterial venous catheter Previous know aortic regurgitation great grade II Contraindications anticoagulation Severe hemolysis cause Patient participate investigational drug device study trial reach primary endpoint interferes current study endpoint .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>